Drug Discovery

In vitro libraries have recently demonstrated the ability to deliver antibodies with affinities comparable to those obtained by immunization

New research in mouse models has uncovered a new mechanism of resistance to KRAS inhibitors

AI enabled solutions accelerate regulatory and medical writing processes, enhancing quality and efficiencies

Per the first author, "the reactome could change the way we think about organic chemistry."

Second generation of the Cancer Dependency Map uncovers priority drug targets with strong links to specific cancer types

Explore the transformative impact of artificial intelligence on drug development and its role in the future of pharmaceutical innovation

Some 42 percent of patients treated with sparsentan showed reduced proteinuria

Patients with HER2-low breast cancers were included in the clinical trial proving the efficacy of trastuzumab deruxtecan monotherapy

Tebotelimab targets two proteins on tumor cells and drives specific immune response safely and effectively

Experts urge EMA to prioritize evidence-based drug development over accelerated marketing authorization